Skip to main content
UniHealth

Doctor search

Kati Lynn Cousins, NP

Nurse Practitioner · Stanford

NPI 1841753043

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Office
1

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Kati Lynn Cousins’s office at (650) 723-4000 to ask if they take your plan before you enroll.

State licence records

1 licence

  • Illinois 209019097Advanced Practice Registered Nurse · since 2019 · expires 2028-05-31
    ActiveNo board action on this licenceCheck it with the state

We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$12,204

Medicare paid this office $12,204 for 118 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)84$9,574$103
Return visit (30+ min)19$1,246$66
Short return visit (20+ min)11$642$49
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or14$455$24

Who their Medicare patients are

118 Original Medicare patients in 2024. Average age 72 · Women 55% · Also on Medicaid 31% · Health risk score 2.56. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.

Conditions among them: High blood pressure 75% · Cancer 54% · Diabetes 36% · Coronary heart disease 36% · Chronic kidney disease 34% · Heart failure 27% · Atrial fibrillation 21% · Depression 19% · COPD 17% · Stroke 11%.

The office billed $75,072, Medicare allowed $16,085 and paid $12,204; for 153 services of 5 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024118153722.56$75,072$12,204
2023135166712.74$46,416$14,122
2022113172703.12$47,006$15,313
20214754692.31$16,050$5,258
201998121702.78$30,028$7,545

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 3 services

Original Medicare services billed in 2023
Long return visit (40+ min)92$10,902$96
Return visit (30+ min)31$2,331$71
Short return visit (20+ min)17$863$48

2022: 3 services

Original Medicare services billed in 2022
Long return visit (40+ min)75$11,887$104
Return visit (30+ min)33$2,466$70
Short return visit (20+ min)19$935$49

2021: 1 service

Original Medicare services billed in 2021
Long return visit (40+ min)40$4,602$105

2019: 3 services

Original Medicare services billed in 2019
Long return visit (40+ min)42$3,742$80
Return visit (30+ min)56$3,380$56
Short return visit (20+ min)11$403$37

Medicaid work

$1,173 in 2023

Medicaid paid $1,173 for 30 billed services this clinician did in 2023, up to 17 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2023
Long return visit (40+ min)30$1,173
Medicaid work by year
202330117$1,173
202249114$2,898
202135116$2,147
See the largest Medicaid services in earlier years

2022

Largest Medicaid services in 2022
Long return visit (40+ min)49$2,898

2021

Largest Medicaid services in 2021
Long return visit (40+ min)35$2,147

Money from drug and device companies

$1,448 in 2025

Industry payments by year
20251232None$1,448
2024712None$319

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
E.R. Squibb & Sons L.L.C.Opdivo$381
3 payments
  • Meals for Breyanzi · 2025-09-30 · $132
  • Meals for Opdivo · 2025-09-09 · $122
  • Meals for Opdivo · 2025-02-11 · $128
AstraZeneca Pharmaceuticals LPCalquence$287
8 payments
  • Meals for Calquence · 2025-10-28 · $30
  • Meals for Calquence · 2025-10-07 · $25
  • Meals for Calquence · 2025-08-29 · $14
  • Meals for Calquence · 2025-08-13 · $23
  • Meals for Calquence · 2025-07-18 · $26
  • Meals · 2025-07-16 · $132
  • Meals for Calquence · 2025-04-25 · $15
  • Meals for Calquence · 2025-04-15 · $22
Syndax PharmaceuticalsRevuforj$193
3 payments
  • Meals for Revuforj · 2025-11-03 · $145
  • Meals · 2025-10-23 · $24
  • Meals · 2025-03-05 · $24
PharmaEssentia USABesremi$122
1 payment
  • Meals for Besremi · 2025-01-27 · $122
Daiichi SankyoVanflyta$101
4 payments
  • Meals for Vanflyta · 2025-11-12 · $29
  • Meals for Enhertu · 2025-09-23 · $14
  • Meals for Vanflyta · 2025-07-31 · $29
  • Meals for Vanflyta · 2025-02-28 · $29
Merck Sharp & DohmeKeytruda$86
3 payments
  • Meals for Keytruda · 2025-10-28 · $28
  • Meals for Keytruda · 2025-10-14 · $27
  • Meals for Keytruda · 2025-07-25 · $31
See all 32 published payments
Every published payment
GlaxoSmithKlineMeals · 2025-12-02Blenrep$17
Takeda Pharmaceuticals U.S.A.Meals · 2025-11-18Vonvendi$30
Daiichi SankyoMeals · 2025-11-12Vanflyta$29
Kite PharmaMeals · 2025-11-11Yescarta$31
Syndax PharmaceuticalsMeals · 2025-11-03Revuforj$145
AstraZeneca Pharmaceuticals LPMeals · 2025-10-28Calquence$30
Merck Sharp & DohmeMeals · 2025-10-28Keytruda$28
Syndax PharmaceuticalsMeals · 2025-10-23None$24
Merck Sharp & DohmeMeals · 2025-10-14Keytruda$27
AstraZeneca Pharmaceuticals LPMeals · 2025-10-07Calquence$25
E.R. Squibb & Sons L.L.C.Meals · 2025-09-30Breyanzi$132
BeOne Medicines USAMeals · 2025-09-29Brukinsa$29
Daiichi SankyoMeals · 2025-09-23Enhertu$14
E.R. Squibb & Sons L.L.C.Meals · 2025-09-09Opdivo$122
BeOne Medicines USAMeals · 2025-09-08Brukinsa$33
Regeneron Healthcare SolutionsMeals · 2025-09-05Lynozyfic$25
AstraZeneca Pharmaceuticals LPMeals · 2025-08-29Calquence$14
AstraZeneca Pharmaceuticals LPMeals · 2025-08-13Calquence$23
Daiichi SankyoMeals · 2025-07-31Vanflyta$29
Merck Sharp & DohmeMeals · 2025-07-25Keytruda$31
AstraZeneca Pharmaceuticals LPMeals · 2025-07-18Calquence$26
AstraZeneca Pharmaceuticals LPMeals · 2025-07-16None$132
AstraZeneca Pharmaceuticals LPMeals · 2025-04-25Calquence$15
AstraZeneca Pharmaceuticals LPMeals · 2025-04-15Calquence$22
Rigel PharmaceuticalsMeals · 2025-04-02Tavalisse$32
Kite PharmaMeals · 2025-03-20Yescarta$28
Syndax PharmaceuticalsMeals · 2025-03-05None$24
Daiichi SankyoMeals · 2025-02-28Vanflyta$29
Rigel PharmaceuticalsMeals · 2025-02-25Tavalisse$28
E.R. Squibb & Sons L.L.C.Meals · 2025-02-11Opdivo$128
PharmaEssentia USAMeals · 2025-01-27Besremi$122
Rigel PharmaceuticalsMeals · 2025-01-22Tavalisse$25
See earlier years (2024)

2024: $319

Payments by company in 2024
AstraZeneca Pharmaceuticals LPCalquence$117
4 payments
  • Meals for Calquence · 2024-12-24 · $29
  • Meals for Calquence · 2024-11-25 · $28
  • Meals for Calquence · 2024-11-05 · $28
  • Meals for Calquence · 2024-09-24 · $31
Lilly USAVerzenio$50
2 payments
  • Meals for Verzenio · 2024-11-12 · $20
  • Meals for Verzenio · 2024-09-18 · $30
Daiichi SankyoVanflyta$38
2 payments
  • Meals for Vanflyta · 2024-12-11 · $21
  • Meals for Vanflyta · 2024-10-01 · $17
Janssen BiotechDarzalex$36
1 payment
  • Meals for Darzalex · 2024-08-27 · $36
Ipsen BiopharmaceuticalsOnivyde$32
1 payment
  • Meals for Onivyde · 2024-11-21 · $32
Kite PharmaYescarta$24
1 payment
  • Meals for Yescarta · 2024-08-26 · $24
Astellas Pharma USNone$23
1 payment
  • Meals · 2024-07-31 · $23

Professional record

NPI
1841753043
Licence
IL 209.019097Illinois 209019097: Active
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Nurse practitioner (363L00000X); Federal specialty code 363LA2200X (363LA2200X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2019-04-13
NPI last updated
2025-12-30
NPI record certified
2025-12-30

This is when the NPI record was last certified, not a medical board exam.

This office lists an electronic records connection.